Drugs / DHEA
last change May 2012 re-read 3 minutes ago

DHEA

Developed for
postmenopausal atrophic vaginitis
Investigated by
EndoCeutics Inc.

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01358760 Jun 2011 → Apr 2012 postmenopausal atrophic vaginitis EndoCeutics Inc. Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DHEA ClinicalTrials.gov intervention name — accepted as the source's own label NCT01358760 ↗